Support First Things by turning your adblocker off or by making a  donation. Thanks!

The international media continues its effort to minimize the Hwang scandal. Whereas before, we were told therapeutic cloning was going to make embryonic stem cell therapy (the most “promising” stem cell form, they tell us in every story despite the utter lack of scientific proof) doable because it would prevent immune rejection: We are now being told in several stories that it was never a realistic likelihood to be used widely in the clinical settings. Yet, when opponents used to say the same thing, we were branded anti-science and stealers of hope.

Also notice that there have been almost no comments in Hwang stories from opponents of cloning research. The purpose of this, it seems to me, is to keep the parameters of the story relatively narrow and permit continuing boosterism of ES cell research as a central focus of attention in the public’s mind despite the continuing cascade of adult/umbilical cord blood stem cell research successes.


Comments are visible to subscribers only. Log in or subscribe to join the conversation.

Tags

Loading...

Filter First Thoughts Posts

Related Articles